Concert Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Concert Wealth Management's PFE Position: Q3 2017 in Review
Concert Wealth Management sold out of Pfizer (PFE) in Q3 2017, closing a stake of 6,859 shares — an estimated $221K sold.
Concert Wealth Management first reported a position in PFE in Q2 2013 and held it in 17 quarters. The position peaked at $6.19M in Q2 2016. 2,040 funds tracked by Wall St. Rank hold PFE as of Q3 2017.
- Concert Wealth Management reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
- Concert Wealth Management sold 6,859 Pfizer shares in Q3 2017, an estimated $221K.
- Concert Wealth Management first reported a position in Pfizer in Q2 2013 and held it in 17 quarters.
- Concert Wealth Management's Pfizer position peaked at $6.19M in Q2 2016.
- 2,040 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.
Based on Concert Wealth Management's 13F filing for Q3 2017, filed 14 Nov 2017.